Agios Pharmaceuticals
Präsenz
Agios Pharmaceuticals ist einer der ...
Agios Pharmaceuticals ist ein Unternehmen, das unter dem Börsenticker AGIO (US) gelistet ist.
Führungskräfte
Siehe das Organigramm mit seine 18 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei Agios Pharmaceuticals
- Brian Goff, Chief Executive Officer and Director
- Jacqualyn Fouse, Chairman of the Board
- Rahul Ballal, Director
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Agios Pharmaceuticals nachzuverfolgen.
Pharmazie
Agios Pharmaceuticals hat 1.863 Konkurrenten , einschließlich Pfizer (USA), Sanofi (Frankreich) und Johnson & Johnson (USA).
Popular M&A news in Pharmazie
- AstraZeneca has announced the acquisition of Fusion Pharma (veröffentlicht am 23, März 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (veröffentlicht am 19, März 2024).
- Frontier Medicines hat gerade eine Spendenaktion von 80 Millionen Dollar angekündigt. (veröffentlicht am 27, Februar 2024).
Andere vorgeschlagene Kontakte der Pharmazie branche
Nachrichten
Neueste Pressemitteilungen nach Agios Pharmaceuticals
- Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020 | Agios Pharmaceuticals, Inc.
- Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia | Agios Pharmaceuticals, Inc.
- Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients | Agios Pharmaceuticals, Inc.
- Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs | Agios Pharmaceuticals, Inc.
- Agios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020 | Agios Pharmaceuticals, Inc.
- Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020 | Agios Pharmaceuticals, Inc.
- Agios Reports Business Highlights and Second Quarter 2020 Financial Results | Agios Pharmaceuticals, Inc.
- Agios to Webcast Conference Call of Second Quarter 2020 Financial Results on July 30, 2020 | Agios Pharmaceuticals, Inc.
- Agios to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on Tuesday, June 23, 2020 | Agios Pharmaceuticals, Inc.
- Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia | Agios Pharmaceuticals, Inc.
- View more press releases Close
Social media about Agios Pharmaceuticals
- Agios Pharmaceuticals auf Wikipedia, Google News & Yahoo Finance
- Agios Pharmaceuticals auf LinkedIn, Twitter & YouTube
In Kontakt kommen
Jetzt seine Führungskräfte, darunter auch Brian Goff, per E-Mail kontaktieren. 
Agios Pharmaceuticals unter +1 617... anrufen
